Boston Scientific hit a new 52-week low of $42.60 on Friday, October 2, 2026, extending its decline. Since spring, when the stock traded above $104, it has lost more than half its value. It has not established a lasting support level during the downturn.
The stock broke below its previous low from mid-July, indicating that selling pressure persists without a major negative catalyst. Sellers have consistently outnumbered buyers during rally attempts over the past year, signaling weak confidence in a potential reversal.
Analysts are watching to see whether the stock stabilizes around its new low or faces further selling pressure.